Beyond the Black Box: A Systematic Review of Breast, Prostate, Colorectal, and Cervical Screening Among Native and Immigrant African-Descent Caribbean Populations

Journal of Immigrant and Minority Health

Volumn 17, Issue 3, 2015, Pages 905-924

  Consedine, Nathan S ^a   Tuck, Natalie L ^a   Ragin, Camille R ^b   Spencer, Benjamin A ^c  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b FOX CHASE CANCER CENTER   (United States)

^c NewYork Presbyterian Hospital   (United States)

Author keywords

African American; Afro Caribbean; Breast; Cancer screening; Cervical; Colorectal; Disparities; Ethnic subpopulations; Prostate

Indexed keywords

BLACK PERSON; CARIBBEAN; EARLY CANCER DIAGNOSIS; HUMAN; MIGRANT; PATIENT PARTICIPATION;

AFRICAN CONTINENTAL ANCESTRY GROUP; CARIBBEAN REGION; EARLY DETECTION OF CANCER; EMIGRANTS AND IMMIGRANTS; HUMANS; PATIENT PARTICIPATION;

EID: 84930086260     PISSN: 15571912     EISSN: 15571920     Source Type: Journal    
DOI: 10.1007/s10903-014-9991-0     Document Type: Article

References (107)

1. ACS. Cancer facts and figures. Atlanta, GA: American Cancer Society; 2011.
2. ACS. Cancer facts and figures for African Americans, 2011–2012. Atlanta, GA: American Cancer Society; 2011.
3. Taksler GB, Keating NL, Cutler DM. Explaining racial differences in prostate cancer mortality. Cancer. 2012;118(17):4280–9.
4. Kinseth MA, Jia Z, Rahmatpanah F, Sawyers A, Sutton M, Wang-Rodriguez J, et al. Expression differences between African American and Caucasian prostate cancer tissue reveals that stroma is the site of aggressive changes. Int J Cancer. 2014;134(1):81–91.
5. Enewold L, Zhou J, McGlynn KA, Devesa SS, Shriver CD, Potter JF, et al. Racial variation in tumor stage at diagnosis among Department of Defense beneficiaries. Cancer. 2012;118(5):1397–403.
6. Desantis C, Naishadham D, Jemal A. Cancer statistics for African Americans, 2013. CA Cancer J Clin. 2013;63(3):151–66.
7. Pinheiro PS, Williams M, Miller EA, Easterday S, Moonie S, Trapido EJ. Cancer survival among Latinos and the Hispanic Paradox. Cancer Causes Control. 2012;22(4):553–61.
8. Shaukat A, Mongin SJ, Geisser MS, Lederle FA, Bond JH, Mandel JS, et al. Long-term mortality after screening for colorectal cancer. N Engl J Med. 2013;369(12):1106–14.
9. Simonella L, Canfell K. The impact of a two-versus three-yearly cervical screening interval recommendation on cervical cancer incidence and mortality: an analysis of trends in Australia, New Zealand, and England. Cancer Causes Control. 2013;24(9):1727–36.
10. Elmunzer BJ, Hayward RA, Schoenfeld PS, Saini SD, Deshpande A, Waljee AK. Effect of flexible sigmoidoscopy based screening on incidence and mortality of colorectal cancer: a systematic review and meta-analysis of randomized controlled trials. PLoS Med. 2012;9(12):e1001352.
11. ACS. Cancer facts and figures for African Americans, 2005–2006. Atlanta, GA: American Cancer Society; 2005.
12. Smith RA, Cokkinides V, Brooks D, Saslow D, Brawley OW. Cancer screening in the United States 2010: a review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin. 2010;60(2):99–119.
13. Schröder FH, Hugosson J, Roobol MJ, Tammela TLJ, Ciatto S, Nelen V, et al. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med. 2009;360(13):1320–8.
14. Berg CD, Andriole GL, Crawford ED, Grubb RL, Buys SS, Chia D, et al. Mortality results from a randomized prostate-cancer screening trial. N Engl J Med. 2009;360(13):1310–9.
15. Gulati R, Mariotto AB, Chen S, Gore JL, Etzioni R. Long-term projections of the harm-benefit trade-off in prostate cancer screening are more favorable than previous short-term estimates. J Clin Epidemiol. 2011;64(12):1412–7.
16. Schröder FH. Stratifying risk—the U. S. Preventive Services Task Force and prostate-cancer screening. N Engl J Med. 2011;365:1953–5.
17. ACS. Cancer detection and early prevention, facts and figures. Atlanta, GA: American Cancer Society; 2010. p. 2010.
18. Jackson JS, Torres M, Caldwell CH, Neighbors HW, Nesse RM, Taylor RJ, et al. The National Survey of American Life: a study of racial, ethnic and cultural influences on mental disorders and mental health. Int J Methods Psychiatr Res. 2004;13(4):196–207.
19. Bach PB, Cramer LD, Warren JL, Begg CB. Racial differences in the treatment of early-stage lung cancer. N Engl J Med. 1999;341(16):1198–205.
20. Ramirez AG, Talavera GA, Villarreal R, Suarez L, McAlister A, Trapido E, et al. Breast cancer screening in regional Hispanic populations. Health Educ Res. 2000;15(5):559–68.
21. O’Malley AS, Kerner J, Johnson AE, Mandelblatt JS. Acculturation and breast cancer screening among Hispanic women in New York city. Am J Public Health. 1999;89(2):219–27.
22. Consedine NS, Magai C. The uncharted waters of emotion: ethnicity, trait emotion and emotion expression in older adults. J Cross Cult Gerontol. 2002;17:71–100.
23. Yaeger R, Avila-Bront A, Abdul K, Nolan PC, Grann VR, Birchette MG, Beckman KB, et al. Comparing genetic ancestry and self-described race in African Americans born in the United States and in Africa. Cancer Epidemiol Biomark Prev. 2008;17(6):1329–88.
24. Torres JB, Kittles RA. The relationship between “race” and genetics in biomedical research. Curr Hypertens Rep. 2007;9(3):196–201.
25. Arthur CM, Katkin ES. Making a case for the examination of ethnicity of Blacks in United States health research. J Healthc Poor Underserved. 2006;17(1):25–36.
26. Consedine NS, Magai C, Conway F. Predicting ethnic variation in adaptation to later life: styles of socioemotional functioning and constrained heterotypy. J Cross Cultural Gerontol. 2004;19:95–129.
27. LaVeist TA. Beyond dummy variables and sample selection: what health services researchers need to know about race as a variable. Health Serv Res. 1994;29:1–16.
28. Phinney JS. When we talk about American ethnic groups, what do we mean? Am Psychol. 1996;51:918–27.
29. Williams DR, Lavizzo-Mourey R, Warren RC. The concept of race and health status in America. Public Health Rep. 1994;109:26–41.
30. Schmidley AD, Gordon C. Profile of the foreign-born population in the United States: 1997. Washington, DC: US Government Printing Office; 1999.
31. Gany FM, Trinh-Shevrin C, Aragones A. Cancer screening and Haitian immigrants: the primary care provider factor. J Immigr Minor Health. 2008;10(3):255–61.
32. Phillips AA, Jacobson JS, Magai C, Consedine NS, Horowitz-Mehler NC, Neugut AI. Cancer incidence and mortality in the Caribbean. Cancer Invest. 2007;25(6):476–83.
33. Planning NYDoC. The Newest New Yorkers 2000: Immigrant New York in the New Millennium. New York, NY: The City of New York Department of Planning; 2004.
34. Singh GP, Siahpush M. Ethnic-immigrant differentials in health behaviors, morbidity, and cause-specific mortality in the United States: an analysis of two national data bases. Hum Biol. 2002;74(1):83–109.
35. Singh GP, Siahpush M. All-cause and cause-specific mortality of immigrants and native born in the United States. Am J Public Health. 2001;91(3):392–9.
36. Bunker CH, Patrick AL, Konety BR, Dhir R, Brufsky AM, Vivas CA, et al. High prevalence of screening-detected prostate cancer among Afro-Caribbeans: The Tobago Prostate Cancer Survey. Cancer Epidemiol Biomark Prev. 2002;11(8):726–9.
37. Glover FE, Coffey DS, Douglas LL, Cadogan M, Russell H, Tulloch T, et al. The epidemiology of prostate cancer in Jamaica. J Urol. 1998;159(6):1984–6.
38. Chinegwundoh F, Enver M, Lee A, Nargund V, Oliver T, Ben-Shlomo Y. Risk and presenting features of prostate cancer amongst African-Caribbean, South Asian and European men in North-east London. BJU Int. 2006;98(6):1216–20.
39. Wild SH, Fischbacher CM, Brock A, Griffiths C, Bhopal R. Mortality from all cancers and lung, colorectal, breast and prostate cancer by country of birth in England and Wales, 2001–2003. Br J Cancer. 2006;94(7):1079–85.
40. Felix AS, Avery G, Mutetwa B, Ishmael R, Ragin C, Taioli E. Cancer screening and cancer mortality in Nevis, West Indies. West Indian Med J. 2009;58(4):311–8.
41. Blake G, Hanchard B, Mitchell K, Simpson D, Waugh N, Wolff C, et al. Jamaica cancer mortality statistics, 1999. West Indian Med J. 2002;51(2):64–7.
42. Taioli E, Attong-Rogers A, Layne P, Roach V, Ragin C. Breast cancer survival in women of African descent living in the US and in the Caribbean: effect of place of birth. Breast Cancer Res Tr. 2010;122(2):515–520.
43. Popay J, Roberts H, Sowden A, Petticrew M, Arai L, Rodgers M, et al. Guidance on the conduct of narrative synthesis in systematic reviews. A product from the ESRC methods programme. Version 2006;1.
44. Morgan M, Kenten C, Deedat S, Team OBotDP. Attitudes to deceased organ donation and registration as a donor among minority ethnic groups in North America and the UK: a synthesis of quantitative and qualitative research. Ethnicity & Health 2012(ahead-of-print):1–24.
45. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.
46. Consedine NS, Horton D, Ungar T, Joe A, Ramirez P, Borrell L. Fear, knowledge and efficacy beliefs differentially predict the frequency of DRE versus PSA screening in ethnically diverse samples of older men. Am J Men’s Health. 2007;1(1):29–43.
47. Gordon NP, Hiatt RA, Lampert DI. Concordance of self-reported data and medical record audit for six cancer screening procedures. J Natl Cancer Inst. 1993;85(7):566–70.
48. Volk RJ, Cass AR. The accuracy of primary care patients’ self-reports of prostate specific antigen testing. Am J Prev Med. 2002;22(1):56–8.
49. Matthews BA, Nattinger AB, Anderson RC. Accuracy and certainty of self-report for colorectal cancer screening among ambulatory patients. Psychol Health Med. 2005;10(1):1–15.
50. Partin MR, Grill J, Noorbaloochi S, Powell AA, Burgess DJ, Vernon SW, et al. Validation of self-reported colorectal cancer screening behavior from a mixed-mode survey of veterans. Cancer Epidemiol Biomark Prev. 2008;17(4):768–76.
51. Baier M, Calonge N, Cutter G, McClatchey M, Schoentgen S, Hines S, et al. Validity of self-reported colorectal cancer screening behavior. Cancer Epidemiol Biomark Prev. 2000;9(2):229–32.
52. Chan ECY, Vernon SW, Ahn C, Greisinger A. Do men know that they have had a prostate-specific antigen test? Accuracy of self-reports of testing at 2 sites. Am J Public Health. 2004;94(8):1336–8.
53. Caplan LS, McQueen DV, Qualters JR, Leff M, Garrett C, Calonge N. Validity of women’s self-reports of cancer screening test utilization in a managed care population. Cancer Epidemiol Biomark Prev. 2003;12(11):1182–7.
54. Robb KA, Power E, Atkin W, Wardle J. Ethnic differences in participation in flexible sigmoidoscopy screening in the UK. J Med Screen. 2008;15(3):130–6.
55. Gorin SS. Correlates of colorectal cancer screening compliance among urban Hispanics. J Behav Med. 2005;28(2):125–37.
56. Pedersen VH, Armes J, Ream E. Perceptions of prostate cancer in Black African and Black Caribbean men: a systematic review of the literature. Psycho-oncology 2011.
57. McNaughton D, Aiken W, McGrowder D. Factors affecting prostate cancer screening behaviour in a discrete population of doctors at the University Hospital of the West Indies, Jamaica. Asian Pac J Cancer Prev. 2011;12:1201–5.
58. Reyes-Ortiz CA, Camacho ME, Amador LF, Velez LF, Ottenbacher KJ, Markides KS. The impact of education and literacy levels on cancer screening among older Latin American and Caribbean adults. Cancer Control. 2007;14(4):388–95.
59. Consedine NS, Adjei BA, Horton D, Joe AK, Borrell LN, Ramirez PM, et al. Fear and loathing in the Caribbean: three studies of fear and cancer screening in Brooklyn’s immigrant Caribbean subpopulations. Infect Agents Cancer 2009;4(Supp. 1):Art. No. S14.
60. Consedine NS, Christie MA, Neugut AI. Physician, affective, and cognitive variables differentially predict “initiation” versus “maintenance” PSA screening profiles in diverse groups of men. Br J Health Psychol. 2009;14(2):303–22.
61. Gonzalez J, Consedine NS, McKiernan JM, Spencer BA. Barriers to initiation and maintenance of PSA screening among African American and Afro-Caribbean men. Urology. 2008;180(6):2403–8.
62. Lee DJ, Consedine NS, Gonzalez JR, Spencer BA. Association of healthcare barriers with prostate-specific antigen screening among African-American and Afro-Caribbean Men. Urology 2012.
63. Lee DJ, Consedine NS, Spencer BA. Barriers and facilitators to digital rectal examination screening among African-American and African-Caribbean men. Urology. 2011;77(4):891–8.
64. Shelton JB, Barocas DA, Conway F, Hart K, Nelson K, Richstone L, et al. Prostate-specific antigen screening in a high-risk population: lessons from the community and how they relate to large-scale population-based studies. Urology. 2005;65(5):931–6.
65. Kleier JA. Fear of and susceptibility to prostate cancer as predictors of prostate cancer screening among Haitian-American men. Urol Nurs. 2010;30(3):179–88.
66. Consedine NS. Are we worrying about the right men and are the right men feeling worried? Conscious but not unconscious prostate anxiety predicts screening among men from three ethnic groups. Am J Men’s Health. 2012;6(1):37–50.
67. Odedina FT, Dagne G, LaRose-Pierre M, Scrivens J, Emanuel F, Adams A, et al. Within-group differences between native-born and foreign-born Black men on prostate cancer risk reduction and early detection practices. J Immigr Minor Health. 2011;13(6):996–1004.
68. Consedine NS, Morgenstern AH, Kudadjie-Gyamfi E, Magai C, Neugut AI. Prostate cancer screening behavior in men from seven ethnic groups: the fear factor. Cancer Epidemiol Biomark Prev. 2006;15(2):228–37.
69. Kudadjie-Gyamfi EK, Consedine NS, Magai C. Predicting digital rectal exam frequency with coping styles. Am J Health Behavior. 2008;32(2):188–200.
70. Kudadjie-Gyamfi EK, Consedine NS, Magai C. On the importance of being ethnic: coping with the threat of prostate cancer in relation to prostate cancer screening. Cult Divers Ethnic Minority Psychol. 2006;12(3):509–26.
71. Soares D, Walters N, Frankson M, Kirlew K, Reid M. Sociocultural deterrents to mammographic screening in Jamaica. West Indian Med J. 2009;58(1):28–32.
72. McFarlane CP, Friedman JS, Goldberg HI, Morris L. Reproductive health survey 1997—Jamaica—final report. Atlanta, GA: U.S. Department of Health and Human Services; 1997.
73. Underwood S, Johnson ER, Callwood G, Evans EE, Matthew A, Scotland-Brooks C, et al. Promoting breast health among women in the U.S. Virgin Islands: a focused study of the needs of Caribbean women. J Natl Black Nurses Assoc 2007;18(2):53–62.
74. Modeste NN, Caleb-Drayton VL, Montgomery S. Barriers to early detection of breast cancer among women in Caribbean populations. Pan Am J Public Health. 1999;5(3):152–6.
75. Kernohan EEM. Evaluation of a pilot study for breast and cervical cancer screening with Bradford’s minority ethnic women; a community development approach, 1991–1993. Br J Cancer. 1996;74(Supp. 29):S42–6.
76. Kudadjie-Gyamfi EK, Magai C, Consedine NS. The obscuring object of race: clinical breast exams and coping styles in ethnic subpopulations of women. Br J Health Psychol. 2010;15(2):289–305.
77. Garbers S, Chiasson MA. Breast cancer screening and health behaviors among African American and Caribbean women in New York City. J Health Care Poor Underserved. 2006;17(1):37–46.
78. Brown N, Naman P, Homel P, Fraser-White M, Clare R, Browne R. Assessment of preventive health knowledge and behaviors of African-American and Afro-Caribbean women in urban settings. J Natl Med Assoc. 2006;98(10):1644–51.
79. Fruchter RG, Wright C, Habenstreit B, Remy JC, Boyce JG, Imperato PJ. Screening for cervical and breast cancer among Caribbean immigrants. J Community Health. 1985;10:121–35.
80. Mandelblatt JS, Gold K, O’Malley AS, Taylor K, Cagney K, Hopkins JS, et al. Breast and cervix cancer screening among multiethnic women: role of age, health and source of care. Prev Med. 1999;28:418–25.
81. David MM, Ko L, Prudent N, Green EH, Posner MA, Freund KM. Mammography use. J Natl Med Assoc. 2005;97(2):253–61.
82. Consedine NS, Magai C, Neugut AI. The contribution of emotional characteristics to breast cancer screening among women from six ethnic groups. Prev Med. 2004;38(1):64–77.
83. Consedine NS, Magai C, Horton D, Neugut AI, Gillespie M. Health belief model factors in mammography screening: testing for interactions among subpopulations of Caribbean women. Ethn Dis. 2005;15(3):444–52.
84. Magai C, Consedine NS, Conway F, Neugut AI, Culver C. Diversity matters: unique populations of older women and breast cancer screening. Cancer. 2004;100(11):2300–7.
85. Brown WM, Consedine NS, Magai C. Time spent in the United States and breast cancer screening behaviors among ethnically diverse immigrant women: evidence for acculturation? J Immigr Minor Health. 2006;8(4):347–58.
86. Kudadjie-Gyamfi EK, Consedine NS, Magai C, Gillespie M, Pierre-Louis J. Breast self-examination practices among women from six ethnic groups and the influence of cancer worry. Breast Cancer Res Treat. 2005;62(1):35–45.
87. Consedine NS. The demographic, system, and psychosocial origins of mammographic screening disparities: prediction of initiation versus maintenance screening among immigrant and non-immigrant women. J Immigr Minor Health. 2012;14(4):570–82.
88. Eluf-Neto J, Nascimento CMR. Cervical cancer in Latin America. Semin Oncol. 2001;28(2):188–97.
89. Kobetz E, Menard J, Barton B, Pierre L, Diem J, Auguste PD. Patnè en aksyon: addressing cancer disparities in Little Haiti through research and social action. Am J Public Health. 2009;99(7):1163–5.
90. Bessler P, Aung M, Jolly P. Factors affecting the uptake of cervical cancer screening among clinic attendees in Trelawny, Jamaica. Cancer Control. 2007;14:396–404.
91. McCaffery K, Forrest S, Waller J, Desai M, Szarewski A, Wardle J. Attitudes towards HPV testing: a qualitative study of beliefs among Indian, Pakistani, African-Caribbean and white British women in the UK. Br J Cancer. 2003;88(1):42–6.
92. Green EH, Freund KM, Posner MA, David MM. Pap smear rates among Haitian immigrant women in eastern Massachusetts. Public Health Rep. 2005;120(2):133–9.
93. Tsui J, Saraiya M, Thompson T, Dey A, Richardson L. Cervical cancer screening among foreign-born women by birthplace and duration in the United States. J Women’s Health. 2007;16(10):1447–57.
94. Reyes-Ortiz CA, Velez LF, Camacho ME, Ottenbacher KJ, Markides KS. Health insurance and cervical cancer screening among older women in Latin American and Caribbean cities. Int J Epidemiol. 2008;37(4):870–8.
95. O’Malley AS, Mandelblatt JS, Gold K, Cagney K, Kerner J. Continuity of care and the use of breast and cervical cancer screening services in a multiethnic community. Arch Intern Med. 1997;157:1462–70.
96. Consedine NS, Ladwig I, Reddig MK, Broadbent EA. The many faeces of colorectal cancer screening embarrassment: preliminary psychometric development and links to screening outcome. Br J Health Psychol. 2011;16(3):559–79.
97. Gwede CK, William CM, Thomas KB, Tarver WL, Quinn GP, Vadaparampil ST, et al. Exploring disparities and variability in perceptions and self-reported colorectal cancer screening among three ethnic subgroups of U.S. blacks. Oncol Nurs Forum. 2010;37(5):581–91.
98. Afable-Munsuz A, Liang S-Y, Ponce NA, Walsh JME. Acculturation and colorectal cancer screening among older Latino adults: differential associations by national origin. J Gen Intern Med. 2009;24(8):963–70.
99. Ragin C, Taioli E. The Second International African-Caribbean Cancer Consortium for the study of viral, genetic and environmental cancer risk factors: meeting report. Infect Agents Cancer 2009;4 Supp. 1(Supp 1):S1.
100. Ragin CC, Taioli E, McFarlane-Anderson N, Avery G, Bennett F, Bovell-Benjamin A, et al. African-Caribbean cancer consortium for the study of viral, genetic and environmental cancer risk factors. Infect Agents Cancer. 2007;2(1):17–22.
101. Creque A, Taioli E, Attong-Rogers A, Ragin C. Disparities in uterine cancer survival in a Brooklyn cohort of black women. Future Oncol. 2010;6(2):319–27.
102. Cobran EK, Wutoh AK, Lee E, Odedina FT, Ragin C, Aiken W, et al. Perceptions of prostate cancer fatalism and screening behavior between United States-born and Caribbean-born Black Males. J Immigr Minor Health 2013. doi:10.1007/s10903-013-9825-5.
103. Mutetwa B, Taioli E, Attong-Rogers A, Layne P, Roach V, Ragin C. Prostate cancer characteristics and survival in males of African Ancestry according to place of birth: data from Brooklyn—New York, Guyana, Tobago and Trinidad. Prostate 2010;70(10):1102–9.
104. Ragin C, Mutetwa B, Attong-Rogers A, Roach V, Taioli E. Geographic and outcome variation among black men diagnosed with prostate cancer. Infect Agents Cancer. 2011;6(Supp. 2):S2.
105. Rebbeck TR, Devesa SS, Chang BL, Bunker CH, Cheng I, Cooney K, et al. Global patterns of prostate cancer incidence, aggressiveness, and mortality in men of african descent. Prostate Cancer 2013.
106. Rogers EN, Jones DZ, Kidd NC, Yeyeodu S, Brock G, Ragin C, et al. Toll-like receptor-associated sequence variants and prostate cancer risk among men of African descent. Genes Immun. 2013;14(6):347–55.
107. Taioli E, Flores-Obando RE, Agalliu I, Blanchet P, Bunker C, Ferrell RE, et al. Multi-institutional prostate cancer study of genetic susceptibility in populations of African descent. Carcinogenesis. 2011;32(9):1361–5.